Arcturus Therapeutics Holdings Inc. (ARCT) Social Stream

Arcturus Therapeutics Holdings Inc. (ARCT): $31.14

-0.08 (-0.26%)

POWR Rating

Component Grades













Featured Post From StockTwits About ARCT

I see $ARCT hitting mid $50’s in the next 2-4 months… their presentation was pretty impressive and with the mRNA vaccines looking as productive and effective as they are… there’s really no limit to where this company can go.
Pjw2079, published July 19, 2021

Other Notable StockTweets About ARCT

$ARCT just found this great interview from early June that I had not seen before. Joe explains in layman's terms what Arcturus does and why their delivery method is unique. He also explains applications beyond vaccines. People who see this just as a covid play are missing out on a company disrupting big pharma. Serious must watch for anybody I treated in learning more about the company

shovelstocks, published July 11, 2021

$ARCT a lot of pancakes on day they’re bullish the next they’re bearish. I’ve been holding and I definitely wish I woulda sold back when it hit $120 but this company is still in a great spot considering variants are popping up, some which can’t be stopped by the current vaccine. I’m holding but if you’re bearish, sell for a loss and leave this thread unless you have some facts to back your sentiments. ✌🏽 ❤️ to all

ThisIsFun22, published July 7, 2021

$ARCT New Press Release:

Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will participate in upcoming investor and scientific conferences. mRNA-Based Therapeutics Summit (Two Presentations) Tuesday, July 13, 2021 (10:30 a.m. ET) Wednesday, July 14, 2021 (12:00 p.m. ET) La (...)

WebChronicleToday, published July 6, 2021

$ARCT reported 4 new insider trades to the SEC in the last 2 minutes.

15,000 shares acquired by Holmes Edward W (Director)
15,000 shares acquired by Barlow James F (Director)
15,000 shares acquired by Parschauer Karah Herdman (Director)
15,000 shares acquired by Marquet Magda (Director)

Newsfilter, published June 22, 2021

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8314 seconds.